These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 30954610)
21. Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees. Marchetti KA; Oerline M; Hollenbeck BK; Kaufman SR; Skolarus TA; Shahinian VB; Caram MEV; Modi PK Urology; 2021 Sep; 155():77-82. PubMed ID: 33610652 [TBL] [Abstract][Full Text] [Related]
22. Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer. Liu J; Womble PR; Merdan S; Miller DC; Montie JE; Denton BT; Urology; 2015 Nov; 86(5):901-5. PubMed ID: 26358397 [TBL] [Abstract][Full Text] [Related]
23. The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Faraj KS; Kaufman SR; Herrel LA; Maganty A; Oerline M; Caram MEV; Shahinian VB; Hollenbeck BK Cancer Med; 2023 Dec; 12(24):22325-22332. PubMed ID: 38100144 [TBL] [Abstract][Full Text] [Related]
24. National Trends in the Utilization of Androgen Deprivation Therapy for Very Low Risk Prostate Cancer. May A; Henke J; Au D; Raza SJ; Davaro F; Hamilton Z; Siddiqui SA Urology; 2019 Aug; 130():79-85. PubMed ID: 31047912 [TBL] [Abstract][Full Text] [Related]
25. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869 [TBL] [Abstract][Full Text] [Related]
26. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study. van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199 [TBL] [Abstract][Full Text] [Related]
27. MUSIC: patterns of care in the radiographic staging of men with newly diagnosed low risk prostate cancer. Ross I; Womble P; Ye J; Linsell S; Montie JE; Miller DC; Cher ML J Urol; 2015 Apr; 193(4):1159-62. PubMed ID: 25444985 [TBL] [Abstract][Full Text] [Related]
28. Contemporary management of prostate cancer: a practice survey of Ontario genitourinary radiation oncologists. Rodrigues G; D'Souza D; Crook J; Malone S; Sathya J; Morton G Radiother Oncol; 2003 Oct; 69(1):63-72. PubMed ID: 14597358 [TBL] [Abstract][Full Text] [Related]
29. Practice Competition and Treatment of Newly Diagnosed Prostate Cancer. Maganty A; Hollenbeck BK; Kaufman SR; Oerline MK; Lai LY; Caram MEV; Shahinian VB Urology; 2023 Jul; 177():95-102. PubMed ID: 37146728 [TBL] [Abstract][Full Text] [Related]
30. [Prevalence and diversity of management of prostate cancer patients classified as low risk using D'Amico group or Cancer of the Prostate Risk Assessment (CAPRA) score: A French multicenter study]. Léon P; Cancel-Tassin G; Koutlidis N; Calves J; Funes de la Vega M; Fournier G; Valeri A; Cormier L; Larré S; Cussenot O Prog Urol; 2017 Mar; 27(3):158-165. PubMed ID: 28258910 [TBL] [Abstract][Full Text] [Related]
31. The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate Cancer. Lester-Coll NH; Park HS; Rutter CE; Corso CD; Mancini BR; Yeboa DN; Kim SP; Gross CP; Yu JB Urology; 2016 Oct; 96():128-135. PubMed ID: 27392652 [TBL] [Abstract][Full Text] [Related]
32. Describing perspectives of health care professionals on active surveillance for the management of prostate cancer. Pang K; Fitch M; Ouellet V; Chevalier S; Drachenberg DE; Finelli A; Lattouf JB; So A; Sutcliffe S; Tanguay S; Saad F; Mes-Masson AM BMC Health Serv Res; 2018 Jun; 18(1):430. PubMed ID: 29884180 [TBL] [Abstract][Full Text] [Related]
33. Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor. Balakrishnan AS; Zhao S; Cowan JE; Broering JM; Cooperberg MR; Carroll PR Urology; 2019 Sep; 131():157-165. PubMed ID: 31150694 [TBL] [Abstract][Full Text] [Related]
34. Practice patterns of Canadian urologists in benign prostatic hyperplasia and prostate cancer. Canadian Prostate Health Council. Ramsey EW; Elhilali M; Goldenberg SL; Nickel CJ; Norman R; Perreault JP; Piercy B; Trachtenberg J J Urol; 2000 Feb; 163(2):499-502. PubMed ID: 10647665 [TBL] [Abstract][Full Text] [Related]
35. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Kim SP; Gross CP; Nguyen PL; Smaldone MC; Shah ND; Karnes RJ; Thompson RH; Han LC; Yu JB; Trinh QD; Ziegenfuss JY; Sun M; Tilburt JC Med Care; 2014 Jul; 52(7):579-85. PubMed ID: 24926704 [TBL] [Abstract][Full Text] [Related]
36. The Clinical Utility of the Genomic Prostate Score in Men with Very Low to Intermediate Risk Prostate Cancer. Gaffney C; Golan R; Cantu MD; Scognamiglio T; McCarthy H; Mosquera JM; McClure TD; Barbieri CE; Robinson BD; Khani F J Urol; 2019 Jul; 202(1):96-101. PubMed ID: 30933552 [TBL] [Abstract][Full Text] [Related]
37. In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer. Hill D; Kaufman SR; Oerline MK; Faraj K; Caram MEV; Shahinian VB; Hollenbeck BK; Maganty A JNCI Cancer Spectr; 2023 Jul; 7(5):. PubMed ID: 37643638 [TBL] [Abstract][Full Text] [Related]
38. National trends in management of localized prostate cancer: A population based analysis 2004-2013. Chen J; Oromendia C; Halpern JA; Ballman KV Prostate; 2018 May; 78(7):512-520. PubMed ID: 29542178 [TBL] [Abstract][Full Text] [Related]
39. Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study. Bandini M; Nazzani S; Marchioni M; Preisser F; Tian Z; Moschini M; Abdollah F; Suardi N; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI Clin Genitourin Cancer; 2019 Feb; 17(1):72-78.e4. PubMed ID: 30342845 [TBL] [Abstract][Full Text] [Related]
40. Change in prostate cancer presentation coinciding with USPSTF screening recommendations at a community-based urology practice. Gaylis FD; Choi JE; Hamilton Z; Dato P; Cohen E; Calabrese R; Prime H; Rosenbaum A; Kader AK Urol Oncol; 2017 Nov; 35(11):663.e1-663.e7. PubMed ID: 28736250 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]